In general, the number of adaptive immune cells, such as activated CD4+ T cells, effector memory CD4+ T cells, type-17 T-helper (Th17) cells, and Th2 cells, in tumor tissue was higher than that in adjacent normal tissue, which indicated an activated immune response in tumor tissue. This evidence concerns the gene CD4 and neoplasm.